APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cognitive Decline

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cognitive Decline Industry Growth and Trends Forecast to 2032

29 December 2025123 pages

Choose your research edition.

Industry ResearchCognitive Decline Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognitive Decline Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Cognitive Decline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognitive Decline Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognitive Decline Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

According to APO Research, the global Cognitive Decline market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cognitive Decline is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cognitive Decline is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cognitive Decline is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cognitive Decline market include Stryker, TrueKAST (Wound Kair Concepts), Thuasne SAS, Talley Group Limited, Smith & Nephew, PROMA REHA, s. r. o., Paramount Bed Holdings Co., Ltd., ORTHOSERVICE AG and Mölnlycke Health Care, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cognitive Decline market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cognitive Decline market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cognitive Decline market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cognitive Decline.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cognitive Decline market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cognitive Decline Market by Company

Stryker

TrueKAST (Wound Kair Concepts)

Thuasne SAS

Talley Group Limited

Smith & Nephew

PROMA REHA, s. r. o.

Paramount Bed Holdings Co., Ltd.

ORTHOSERVICE AG

Mölnlycke Health Care

Medtronic

Medline Industries Inc.

Linet spol. S R.O.

Invacare Corporation

Hollister Incorporated

Hill-Rom Services Inc.

Drive DeVilbiss Healthcare Ltd (Sidhil Limited)

DJO Global

DeRoyal Industries

DARCO International

ConvaTec Group plc

Coloplast A/S

BSN Medical (Essity)

Breg, Inc.

ArjoHuntleigh

Apex Medical Corp.

ALGEOS

Advanced Orthopaedics

Cognitive Decline Segment by Type

by Drug Therapy

by Non-Invasive Stimulation Devices

Cognitive Decline Segment by Application

Mild Cognitive Impairment (MCI)

Dementia

Cognitive Decline Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Decline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Decline and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Decline.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cognitive Decline companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cognitive Decline Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cognitive Decline Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cognitive Decline Market Share by Region (2021-2026) Table 4. Global Cognitive Decline Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cognitive Decline Market Share by Region (2027-2032) Table 6. Global Cognitive Decline Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cognitive Decline Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cognitive Decline Market Size Share by Type (2021-2026) Table 9. Global Cognitive Decline Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cognitive Decline Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cognitive Decline Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cognitive Decline Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cognitive Decline Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cognitive Decline Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cognitive Decline Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cognitive Decline Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cognitive Decline Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cognitive Decline Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cognitive Decline Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cognitive Decline Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cognitive Decline Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cognitive Decline Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cognitive Decline Market Size Share by Application (2021-2026) Table 24. Global Cognitive Decline Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cognitive Decline Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cognitive Decline Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cognitive Decline Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cognitive Decline Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cognitive Decline Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cognitive Decline Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cognitive Decline Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cognitive Decline Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cognitive Decline Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cognitive Decline Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cognitive Decline Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cognitive Decline Industry Trends Table 37. Cognitive Decline Industry Drivers Table 38. Cognitive Decline Industry Opportunities and Challenges Table 39. Cognitive Decline Industry Restraints Table 40. Global Cognitive Decline Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cognitive Decline Revenue Market Share by Company (2021-2026) Table 42. Global Cognitive Decline Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cognitive Decline Key Company Headquarters & Area Served Table 44. Global Cognitive Decline Company, Product Type & Application Table 45. Global Cognitive Decline Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cognitive Decline by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Stryker Company Information Table 49. Stryker Business Overview Table 50. Stryker Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Stryker Cognitive Decline Product Portfolio Table 52. Stryker Recent Development Table 53. TrueKAST (Wound Kair Concepts) Company Information Table 54. TrueKAST (Wound Kair Concepts) Business Overview Table 55. TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. TrueKAST (Wound Kair Concepts) Cognitive Decline Product Portfolio Table 57. TrueKAST (Wound Kair Concepts) Recent Development Table 58. Thuasne SAS Company Information Table 59. Thuasne SAS Business Overview Table 60. Thuasne SAS Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Thuasne SAS Cognitive Decline Product Portfolio Table 62. Thuasne SAS Recent Development Table 63. Talley Group Limited Company Information Table 64. Talley Group Limited Business Overview Table 65. Talley Group Limited Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Talley Group Limited Cognitive Decline Product Portfolio Table 67. Talley Group Limited Recent Development Table 68. Smith & Nephew Company Information Table 69. Smith & Nephew Business Overview Table 70. Smith & Nephew Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Smith & Nephew Cognitive Decline Product Portfolio Table 72. Smith & Nephew Recent Development Table 73. PROMA REHA, s. r. o. Company Information Table 74. PROMA REHA, s. r. o. Business Overview Table 75. PROMA REHA, s. r. o. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. PROMA REHA, s. r. o. Cognitive Decline Product Portfolio Table 77. PROMA REHA, s. r. o. Recent Development Table 78. Paramount Bed Holdings Co., Ltd. Company Information Table 79. Paramount Bed Holdings Co., Ltd. Business Overview Table 80. Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Portfolio Table 82. Paramount Bed Holdings Co., Ltd. Recent Development Table 83. ORTHOSERVICE AG Company Information Table 84. ORTHOSERVICE AG Business Overview Table 85. ORTHOSERVICE AG Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. ORTHOSERVICE AG Cognitive Decline Product Portfolio Table 87. ORTHOSERVICE AG Recent Development Table 88. Mölnlycke Health Care Company Information Table 89. Mölnlycke Health Care Business Overview Table 90. Mölnlycke Health Care Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Mölnlycke Health Care Cognitive Decline Product Portfolio Table 92. Mölnlycke Health Care Recent Development Table 93. Medtronic Company Information Table 94. Medtronic Business Overview Table 95. Medtronic Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Medtronic Cognitive Decline Product Portfolio Table 97. Medtronic Recent Development Table 98. Medline Industries Inc. Company Information Table 99. Medline Industries Inc. Business Overview Table 100. Medline Industries Inc. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Medline Industries Inc. Cognitive Decline Product Portfolio Table 102. Medline Industries Inc. Recent Development Table 103. Linet spol. S R.O. Company Information Table 104. Linet spol. S R.O. Business Overview Table 105. Linet spol. S R.O. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Linet spol. S R.O. Cognitive Decline Product Portfolio Table 107. Linet spol. S R.O. Recent Development Table 108. Invacare Corporation Company Information Table 109. Invacare Corporation Business Overview Table 110. Invacare Corporation Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Invacare Corporation Cognitive Decline Product Portfolio Table 112. Invacare Corporation Recent Development Table 113. Hollister Incorporated Company Information Table 114. Hollister Incorporated Business Overview Table 115. Hollister Incorporated Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Hollister Incorporated Cognitive Decline Product Portfolio Table 117. Hollister Incorporated Recent Development Table 118. Hill-Rom Services Inc. Company Information Table 119. Hill-Rom Services Inc. Business Overview Table 120. Hill-Rom Services Inc. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Hill-Rom Services Inc. Cognitive Decline Product Portfolio Table 122. Hill-Rom Services Inc. Recent Development Table 123. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information Table 124. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview Table 125. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Portfolio Table 127. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Development Table 128. DJO Global Company Information Table 129. DJO Global Business Overview Table 130. DJO Global Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. DJO Global Cognitive Decline Product Portfolio Table 132. DJO Global Recent Development Table 133. DeRoyal Industries Company Information Table 134. DeRoyal Industries Business Overview Table 135. DeRoyal Industries Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. DeRoyal Industries Cognitive Decline Product Portfolio Table 137. DeRoyal Industries Recent Development Table 138. DARCO International Company Information Table 139. DARCO International Business Overview Table 140. DARCO International Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. DARCO International Cognitive Decline Product Portfolio Table 142. DARCO International Recent Development Table 143. ConvaTec Group plc Company Information Table 144. ConvaTec Group plc Business Overview Table 145. ConvaTec Group plc Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. ConvaTec Group plc Cognitive Decline Product Portfolio Table 147. ConvaTec Group plc Recent Development Table 148. Coloplast A/S Company Information Table 149. Coloplast A/S Business Overview Table 150. Coloplast A/S Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Coloplast A/S Cognitive Decline Product Portfolio Table 152. Coloplast A/S Recent Development Table 153. BSN Medical (Essity) Company Information Table 154. BSN Medical (Essity) Business Overview Table 155. BSN Medical (Essity) Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. BSN Medical (Essity) Cognitive Decline Product Portfolio Table 157. BSN Medical (Essity) Recent Development Table 158. Breg, Inc. Company Information Table 159. Breg, Inc. Business Overview Table 160. Breg, Inc. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Breg, Inc. Cognitive Decline Product Portfolio Table 162. Breg, Inc. Recent Development Table 163. ArjoHuntleigh Company Information Table 164. ArjoHuntleigh Business Overview Table 165. ArjoHuntleigh Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. ArjoHuntleigh Cognitive Decline Product Portfolio Table 167. ArjoHuntleigh Recent Development Table 168. Apex Medical Corp. Company Information Table 169. Apex Medical Corp. Business Overview Table 170. Apex Medical Corp. Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Apex Medical Corp. Cognitive Decline Product Portfolio Table 172. Apex Medical Corp. Recent Development Table 173. ALGEOS Company Information Table 174. ALGEOS Business Overview Table 175. ALGEOS Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. ALGEOS Cognitive Decline Product Portfolio Table 177. ALGEOS Recent Development Table 178. Advanced Orthopaedics Company Information Table 179. Advanced Orthopaedics Business Overview Table 180. Advanced Orthopaedics Cognitive Decline Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Advanced Orthopaedics Cognitive Decline Product Portfolio Table 182. Advanced Orthopaedics Recent Development Table 183. North America Cognitive Decline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. North America Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 185. North America Cognitive Decline Market Share by Country (2021-2026) Table 186. North America Cognitive Decline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. North America Cognitive Decline Market Share Forecast by Country (2027-2032) Table 188. Europe Cognitive Decline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Europe Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 190. Europe Cognitive Decline Market Share by Country (2021-2026) Table 191. Europe Cognitive Decline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Europe Cognitive Decline Market Share Forecast by Country (2027-2032) Table 193. Asia-Pacific Cognitive Decline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Asia-Pacific Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 195. Asia-Pacific Cognitive Decline Market Share by Country (2021-2026) Table 196. Asia-Pacific Cognitive Decline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Asia-Pacific Cognitive Decline Market Share Forecast by Country (2027-2032) Table 198. Latin America Cognitive Decline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Latin America Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 200. Latin America Cognitive Decline Market Share by Country (2021-2026) Table 201. Latin America Cognitive Decline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Latin America Cognitive Decline Market Share Forecast by Country (2027-2032) Table 203. Middle East & Africa Cognitive Decline Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East & Africa Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East & Africa Cognitive Decline Market Share by Country (2021-2026) Table 206. Middle East & Africa Cognitive Decline Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East & Africa Cognitive Decline Market Share Forecast by Country (2027-2032) Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cognitive Decline Product Image Figure 3. Global Cognitive Decline Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cognitive Decline Market Size (2021-2032) & (US$ Million) Figure 5. Global Cognitive Decline Market Share by Region: 2025 VS 2032 Figure 6. Global Cognitive Decline Market Share by Region (2021-2032) Figure 7. North America Cognitive Decline Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cognitive Decline Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cognitive Decline Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cognitive Decline Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cognitive Decline Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Type One Image Figure 13. Type Two Image Figure 14. Global Cognitive Decline Market Size Overview by Type (2021-2032) & (US$ Million) Figure 15. Global Cognitive Decline Market Share by Type 2025 VS 2032 Figure 16. North America Cognitive Decline Market Size Share by Type (2021-2032) Figure 17. Europe Cognitive Decline Market Size Share by Type (2021-2032) Figure 18. Asia-Pacific Cognitive Decline Market Size Share by Type (2021-2032) Figure 19. Latin America Cognitive Decline Market Size Share by Type (2021-2032) Figure 20. Middle East and Africa Cognitive Decline Market Size Share by Type (2021-2032) Figure 21. Mild Cognitive Impairment (MCI) Image Figure 22. Global Mild Cognitive Impairment (MCI) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. Dementia Image Figure 24. Global Dementia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Global Cognitive Decline Market Size Overview by Application (2021-2032) & (US$ Million) Figure 26. Global Cognitive Decline Market Share by Application 2025 VS 2032 Figure 27. North America Cognitive Decline Market Size Share by Application (2021-2032) Figure 28. Europe Cognitive Decline Market Size Share by Application (2021-2032) Figure 29. Asia-Pacific Cognitive Decline Market Size Share by Application (2021-2032) Figure 30. Latin America Cognitive Decline Market Size Share by Application (2021-2032) Figure 31. Middle East and Africa Cognitive Decline Market Size Share by Application (2021-2032) Figure 32. Global Top 5 and 10 Cognitive Decline Players Market Share by Revenue in 2025 Figure 33. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. North America Cognitive Decline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 35. North America Cognitive Decline Market Share by Country: 2021 VS 2025 VS 2032 Figure 36. North America Cognitive Decline Market Share by Country (2021-2032) Figure 37. Europe Cognitive Decline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 38. Europe Cognitive Decline Market Share by Country: 2021 VS 2025 VS 2032 Figure 39. Europe Cognitive Decline Market Share by Country (2021-2032) Figure 40. Asia-Pacific Cognitive Decline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. Asia-Pacific Cognitive Decline Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. Asia-Pacific Cognitive Decline Market Share by Country (2021-2032) Figure 43. Latin America Cognitive Decline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Latin America Cognitive Decline Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Latin America Cognitive Decline Market Share by Country (2021-2032) Figure 46. Middle East & Africa Cognitive Decline Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Middle East & Africa Cognitive Decline Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Middle East & Africa Cognitive Decline Market Share by Country (2021-2032) Figure 49. Years Considered Figure 50. Research Process Figure 51. Key Executives Interviewed

Scope & coverage.

Applications
  • Mild Cognitive Impairment (MCI)
  • Dementia
Companies covered
  • Stryker
  • TrueKAST (Wound Kair Concepts)
  • Thuasne SAS
  • Talley Group Limited
  • Smith & Nephew
  • PROMA REHA, s. r. o.
  • Paramount Bed Holdings Co., Ltd.
  • ORTHOSERVICE AG
  • Mölnlycke Health Care
  • Medtronic
  • Medline Industries Inc.
  • Linet spol. S R.O.
  • Invacare Corporation
  • Hollister Incorporated
  • Hill-Rom Services Inc.
  • Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  • DJO Global
  • DeRoyal Industries
  • DARCO International
  • ConvaTec Group plc
  • Coloplast A/S
  • BSN Medical (Essity)
  • Breg, Inc.
  • ArjoHuntleigh
  • Apex Medical Corp.
  • ALGEOS
  • Advanced Orthopaedics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cognitive Decline Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cognitive Decline Market Size by Region (2021-2032)
  5. 1.4.1 Global Cognitive Decline Market Size by Region (2021-2026)
  6. 1.4.2 Global Cognitive Decline Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cognitive Decline Market Size (2021-2032)
  8. 1.5.1 North America Cognitive Decline Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cognitive Decline Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cognitive Decline Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cognitive Decline Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cognitive Decline Market Size Growth Rate (2021-2032)
2 Cognitive Decline Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 by Drug Therapy
  3. 2.1.2 by Non-Invasive Stimulation Devices
  4. 2.2 Global Cognitive Decline Market Size by Type
  5. 2.2.1 Global Cognitive Decline Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cognitive Decline Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cognitive Decline Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cognitive Decline Market Size by Regions
  9. 2.3.1 North America Cognitive Decline Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cognitive Decline Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cognitive Decline Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cognitive Decline Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cognitive Decline Market Size Breakdown by Type (2021-2026)
3 Cognitive Decline Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Mild Cognitive Impairment (MCI)
  3. 3.1.2 Dementia
  4. 3.2 Global Cognitive Decline Market Size by Application
  5. 3.2.1 Global Cognitive Decline Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Cognitive Decline Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Cognitive Decline Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Cognitive Decline Market Size by Regions
  9. 3.3.1 North America Cognitive Decline Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Cognitive Decline Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Cognitive Decline Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Cognitive Decline Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Cognitive Decline Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cognitive Decline Industry Trends
  2. 4.2 Cognitive Decline Industry Drivers
  3. 4.3 Cognitive Decline Industry Opportunities and Challenges
  4. 4.4 Cognitive Decline Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cognitive Decline Revenue (2021-2026)
  2. 5.2 Global Cognitive Decline Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cognitive Decline Key Company Headquarters & Area Served
  4. 5.4 Global Cognitive Decline Company, Product Type & Application
  5. 5.5 Global Cognitive Decline Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cognitive Decline Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cognitive Decline Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cognitive Decline Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Stryker
  2. 6.1.1 Stryker Company Information
  3. 6.1.2 Stryker Business Overview
  4. 6.1.3 Stryker Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Stryker Cognitive Decline Product Portfolio
  6. 6.1.5 Stryker Recent Developments
  7. 6.2 TrueKAST (Wound Kair Concepts)
  8. 6.2.1 TrueKAST (Wound Kair Concepts) Company Information
  9. 6.2.2 TrueKAST (Wound Kair Concepts) Business Overview
  10. 6.2.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 TrueKAST (Wound Kair Concepts) Cognitive Decline Product Portfolio
  12. 6.2.5 TrueKAST (Wound Kair Concepts) Recent Developments
  13. 6.3 Thuasne SAS
  14. 6.3.1 Thuasne SAS Company Information
  15. 6.3.2 Thuasne SAS Business Overview
  16. 6.3.3 Thuasne SAS Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Thuasne SAS Cognitive Decline Product Portfolio
  18. 6.3.5 Thuasne SAS Recent Developments
  19. 6.4 Talley Group Limited
  20. 6.4.1 Talley Group Limited Company Information
  21. 6.4.2 Talley Group Limited Business Overview
  22. 6.4.3 Talley Group Limited Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Talley Group Limited Cognitive Decline Product Portfolio
  24. 6.4.5 Talley Group Limited Recent Developments
  25. 6.5 Smith & Nephew
  26. 6.5.1 Smith & Nephew Company Information
  27. 6.5.2 Smith & Nephew Business Overview
  28. 6.5.3 Smith & Nephew Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Smith & Nephew Cognitive Decline Product Portfolio
  30. 6.5.5 Smith & Nephew Recent Developments
  31. 6.6 PROMA REHA, s. r. o.
  32. 6.6.1 PROMA REHA, s. r. o. Company Information
  33. 6.6.2 PROMA REHA, s. r. o. Business Overview
  34. 6.6.3 PROMA REHA, s. r. o. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 PROMA REHA, s. r. o. Cognitive Decline Product Portfolio
  36. 6.6.5 PROMA REHA, s. r. o. Recent Developments
  37. 6.7 Paramount Bed Holdings Co., Ltd.
  38. 6.7.1 Paramount Bed Holdings Co., Ltd. Company Information
  39. 6.7.2 Paramount Bed Holdings Co., Ltd. Business Overview
  40. 6.7.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Portfolio
  42. 6.7.5 Paramount Bed Holdings Co., Ltd. Recent Developments
  43. 6.8 ORTHOSERVICE AG
  44. 6.8.1 ORTHOSERVICE AG Company Information
  45. 6.8.2 ORTHOSERVICE AG Business Overview
  46. 6.8.3 ORTHOSERVICE AG Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 ORTHOSERVICE AG Cognitive Decline Product Portfolio
  48. 6.8.5 ORTHOSERVICE AG Recent Developments
  49. 6.9 Mölnlycke Health Care
  50. 6.9.1 Mölnlycke Health Care Company Information
  51. 6.9.2 Mölnlycke Health Care Business Overview
  52. 6.9.3 Mölnlycke Health Care Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Mölnlycke Health Care Cognitive Decline Product Portfolio
  54. 6.9.5 Mölnlycke Health Care Recent Developments
  55. 6.10 Medtronic
  56. 6.10.1 Medtronic Company Information
  57. 6.10.2 Medtronic Business Overview
  58. 6.10.3 Medtronic Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Medtronic Cognitive Decline Product Portfolio
  60. 6.10.5 Medtronic Recent Developments
  61. 6.11 Medline Industries Inc.
  62. 6.11.1 Medline Industries Inc. Company Information
  63. 6.11.2 Medline Industries Inc. Business Overview
  64. 6.11.3 Medline Industries Inc. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Medline Industries Inc. Cognitive Decline Product Portfolio
  66. 6.11.5 Medline Industries Inc. Recent Developments
  67. 6.12 Linet spol. S R.O.
  68. 6.12.1 Linet spol. S R.O. Company Information
  69. 6.12.2 Linet spol. S R.O. Business Overview
  70. 6.12.3 Linet spol. S R.O. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Linet spol. S R.O. Cognitive Decline Product Portfolio
  72. 6.12.5 Linet spol. S R.O. Recent Developments
  73. 6.13 Invacare Corporation
  74. 6.13.1 Invacare Corporation Company Information
  75. 6.13.2 Invacare Corporation Business Overview
  76. 6.13.3 Invacare Corporation Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Invacare Corporation Cognitive Decline Product Portfolio
  78. 6.13.5 Invacare Corporation Recent Developments
  79. 6.14 Hollister Incorporated
  80. 6.14.1 Hollister Incorporated Company Information
  81. 6.14.2 Hollister Incorporated Business Overview
  82. 6.14.3 Hollister Incorporated Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Hollister Incorporated Cognitive Decline Product Portfolio
  84. 6.14.5 Hollister Incorporated Recent Developments
  85. 6.15 Hill-Rom Services Inc.
  86. 6.15.1 Hill-Rom Services Inc. Company Information
  87. 6.15.2 Hill-Rom Services Inc. Business Overview
  88. 6.15.3 Hill-Rom Services Inc. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Hill-Rom Services Inc. Cognitive Decline Product Portfolio
  90. 6.15.5 Hill-Rom Services Inc. Recent Developments
  91. 6.16 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  92. 6.16.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information
  93. 6.16.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
  94. 6.16.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Portfolio
  96. 6.16.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
  97. 6.17 DJO Global
  98. 6.17.1 DJO Global Company Information
  99. 6.17.2 DJO Global Business Overview
  100. 6.17.3 DJO Global Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 DJO Global Cognitive Decline Product Portfolio
  102. 6.17.5 DJO Global Recent Developments
  103. 6.18 DeRoyal Industries
  104. 6.18.1 DeRoyal Industries Company Information
  105. 6.18.2 DeRoyal Industries Business Overview
  106. 6.18.3 DeRoyal Industries Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 DeRoyal Industries Cognitive Decline Product Portfolio
  108. 6.18.5 DeRoyal Industries Recent Developments
  109. 6.19 DARCO International
  110. 6.19.1 DARCO International Company Information
  111. 6.19.2 DARCO International Business Overview
  112. 6.19.3 DARCO International Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 DARCO International Cognitive Decline Product Portfolio
  114. 6.19.5 DARCO International Recent Developments
  115. 6.20 ConvaTec Group plc
  116. 6.20.1 ConvaTec Group plc Company Information
  117. 6.20.2 ConvaTec Group plc Business Overview
  118. 6.20.3 ConvaTec Group plc Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 ConvaTec Group plc Cognitive Decline Product Portfolio
  120. 6.20.5 ConvaTec Group plc Recent Developments
  121. 6.21 Coloplast A/S
  122. 6.21.1 Coloplast A/S Company Information
  123. 6.21.2 Coloplast A/S Business Overview
  124. 6.21.3 Coloplast A/S Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Coloplast A/S Cognitive Decline Product Portfolio
  126. 6.21.5 Coloplast A/S Recent Developments
  127. 6.22 BSN Medical (Essity)
  128. 6.22.1 BSN Medical (Essity) Company Information
  129. 6.22.2 BSN Medical (Essity) Business Overview
  130. 6.22.3 BSN Medical (Essity) Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 BSN Medical (Essity) Cognitive Decline Product Portfolio
  132. 6.22.5 BSN Medical (Essity) Recent Developments
  133. 6.23 Breg, Inc.
  134. 6.23.1 Breg, Inc. Company Information
  135. 6.23.2 Breg, Inc. Business Overview
  136. 6.23.3 Breg, Inc. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Breg, Inc. Cognitive Decline Product Portfolio
  138. 6.23.5 Breg, Inc. Recent Developments
  139. 6.24 ArjoHuntleigh
  140. 6.24.1 ArjoHuntleigh Company Information
  141. 6.24.2 ArjoHuntleigh Business Overview
  142. 6.24.3 ArjoHuntleigh Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 ArjoHuntleigh Cognitive Decline Product Portfolio
  144. 6.24.5 ArjoHuntleigh Recent Developments
  145. 6.25 Apex Medical Corp.
  146. 6.25.1 Apex Medical Corp. Company Information
  147. 6.25.2 Apex Medical Corp. Business Overview
  148. 6.25.3 Apex Medical Corp. Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Apex Medical Corp. Cognitive Decline Product Portfolio
  150. 6.25.5 Apex Medical Corp. Recent Developments
  151. 6.26 ALGEOS
  152. 6.26.1 ALGEOS Company Information
  153. 6.26.2 ALGEOS Business Overview
  154. 6.26.3 ALGEOS Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 ALGEOS Cognitive Decline Product Portfolio
  156. 6.26.5 ALGEOS Recent Developments
  157. 6.27 Advanced Orthopaedics
  158. 6.27.1 Advanced Orthopaedics Company Information
  159. 6.27.2 Advanced Orthopaedics Business Overview
  160. 6.27.3 Advanced Orthopaedics Cognitive Decline Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Advanced Orthopaedics Cognitive Decline Product Portfolio
  162. 6.27.5 Advanced Orthopaedics Recent Developments
7 North America
  1. 7.1 North America Cognitive Decline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cognitive Decline Market Size by Country (2021-2026)
  3. 7.3 North America Cognitive Decline Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cognitive Decline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cognitive Decline Market Size by Country (2021-2026)
  3. 8.3 Europe Cognitive Decline Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cognitive Decline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cognitive Decline Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cognitive Decline Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cognitive Decline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cognitive Decline Market Size by Country (2021-2026)
  3. 10.3 South America Cognitive Decline Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cognitive Decline Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cognitive Decline Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cognitive Decline Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst